Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Tax Provisions came in at $3870.0 in Q2 2026, down 31.76% year-over-year from $5671.0 in Q2 2025, and little changed quarter-over-quarter from $3871.0 in Q1 2026.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Tax Provisions (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Tax Provisions across 17 years of filings, most recently posting $3870.0 for Q2 2026.
- In Q2 2026, Tax Provisions fell 31.76% year-over-year to $3870.0; the TTM figure through Jun 2026 stood at $36656.0 (up 207.14% YoY), while the FY2025 annual figure was $40256.0, up 277.58% from the prior year.
- Tax Provisions came in at $3870.0 for Q2 2026 at Cumberland Pharmaceuticals, roughly flat from $3871.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $48150.0 in Q4 2022 to a low of -$56996.0 in Q4 2024.
- Average Tax Provisions over 5 years is $7774.8, with a median of $6918.5 recorded in 2022.
- Year-over-year, Tax Provisions jumped 284.71% in 2022 and slumped 328.39% in 2024.
- Over 5 years, Tax Provisions stood at $48150.0 in 2022, then tumbled by 48.17% to $24956.0 in 2023, then plunged by 328.39% to -$56996.0 in 2024, then surged by 140.78% to $23245.0 in 2025, then tumbled by 83.35% to $3870.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $3870.0 in Q2 2026, $3871.0 in Q1 2026, and $23245.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -407.00 Mn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | -524.23 Mn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 165.91 Mn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 39.70 Mn |
| 10 | Cumberland Pharmaceuticals | 96.11 Mn | 92.24 Mn | - | 3,870.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,870.00 |
| Mar 31, 2026 | 3,871.00 |
| Dec 31, 2025 | 23,245.00 |
| Sep 30, 2025 | 5,670.00 |
| Jun 30, 2025 | 5,671.00 |
| Mar 31, 2025 | 5,670.00 |
| Dec 31, 2024 | -56,996.00 |
| Sep 30, 2024 | 11,442.00 |
| Jun 30, 2024 | 11,443.00 |
| Mar 31, 2024 | 11,442.00 |
| Dec 31, 2023 | 24,956.00 |
| Sep 30, 2023 | 6,938.00 |
| Jun 30, 2023 | 6,937.00 |
| Mar 31, 2023 | 6,938.00 |
| Dec 31, 2022 | 48,150.00 |
| Sep 30, 2022 | 6,900.00 |
| Jun 30, 2022 | 6,900.00 |
| Mar 31, 2022 | 6,900.00 |
| Dec 31, 2021 | 12,516.00 |
| Sep 30, 2021 | 7,458.00 |